EP3658140
Samsetningar af aprósítentan með öðrum virkum efnum til meðhöndlunar á erfiðum háþrýstingi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
6.11.2017EP published:
21.5.2025EP application number:
17794712.4
EP translation filed:
13.8.2025Grant published:
15.9.2025EPO information:
European Patent Register
Max expiry date:
5.11.2037Expiry date:
5.11.2026Next due date:
30.11.2026
Title in English:
COMBINATIONS OF APROCITENTAN WITH FURTHER ACTIVE INGREDIENTS FOR THE TREATMENT OF RESISTANT HYPERTENSIONLanguage of the patent:
English
Timeline
Today
6.11.2017EP application
21.5.2025EP Publication
13.8.2025Translation submitted
15.9.2025Registration published
5.11.2026Expires
Owner
Name:
Idorsia Pharmaceuticals LtdAddress:
Hegenheimermattweg 91, 4123 Allschwil, CH
Inventor
Name:
BELLET, MarcAddress:
4123 Allschwil, CH
Name:
BOLLI, MartinAddress:
4123 Allschwil, CH
Name:
CLOZEL, MartineAddress:
4123 Allschwil, CH
Name:
IGLARZ, MarcAddress:
4123 Allschwil, CH
Name:
KOHLER, PhilippAddress:
4123 Allschwil, CH
Name:
SCHINDELHOLZ, IvanAddress:
4123 Allschwil, CH
Name:
VON RAUMER, MarkusAddress:
4123 Allschwil, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/EP2017/054489Date:
27.2.2017Country:
WO
Number:
PCT/EP2017/061487Date:
12.5.2017Country:
WO
Classification
Categories:
A61K 31/401, A61K 31/506, A61K 45/06, A61K 31/4422, A61K 31/513, A61K 31/549, A61P 9/12, A61K 31/41
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 11.11.2025
Expires: 5.11.2026
Payer: G.H. Sigurgeirsson ehf.